Owner of firm linked to deadly meningitis outbreak takes Fifth before Congress

The owner of a company linked to a deadly fungal meningitis outbreak cited his constitutional right to remain silent Wednesday before a congressional subcommittee investigating the firm and 32 deaths nationwide.

Barry Cadden, owner and director of the New England Compounding Center, was questioned by Rep. Cliff Stearns, R-Florida, chairman of the House Energy and Commerce Committee's Subcommittee on Oversight and Investigations. Cadden was subpoenaed to appear before the body, his spokesman said.

"Let me be clear, Mr. Cadden," Stearns said. "Again, are you refusing to answer the questions on the basis of the protections afforded to you under the Fifth Amendment to the United States Constitution?"

"Under the advice of counsel, I respectfully decline to answer on the basis of my constitutional rights and privileges," Cadden said.

Stearns: "Will you invoke your Fifth Amendment rights in response to all questions today?"

Cadden: "Yes."

Stearns then excused Cadden and advised him the subcommittee may recall him.

"Thank you, Mr. Chairman," Cadden said.

The subcommittee is investigating what went wrong at the compounding company and why it was able to continue to function despite a history of problems.

The fungal meningitis outbreak has killed 32 people in seven states as of Friday, the Centers for Disease Control and Prevention said on its website. It also reports of a total of 438 cases linked to the outbreak.

Patients contracted the deadly fungal meningitis after being injected in their spines with a contaminated preservative-free steroid called methylprednisolone acetate. The steroid is used to treat pain and inflammation.

The New England Compounding Center voluntarily recalled three lots.

Meanwhile, federal authorities have launched a criminal investigation into the practices at the Framingham-based company, Massachusetts Gov. Deval Patrick has said.

In addition, the state Board of Registration in Pharmacy has voted to revoke permanently the company's license to operate in Massachusetts as well as the licenses of the company's three principal pharmacists, Patrick said.

CNN's Danielle Dellorto contributed to this report.


Comments

Related Stories

Princeton University considers meningitis vaccine after 7 confirmed cases Princeton University considers meningitis vaccine after 7 confirmed cases

Princeton University officials are weighing whether to give students a meningitis vaccine that hasn't been approved in the U.S. to stop the spread of the sometimes deadly disease.

Viral meningitis confirmed in student at Avon High School Viral meningitis confirmed in student at Avon High School

Avon Local Schools now knows that a student at Avon High School with a suspected case of viral meningitis did contract the virus.

Dozens sue pharmacy over meningitis, but compensation uncertain Dozens sue pharmacy over meningitis, but compensation uncertain

The lawsuits allege that NECC negligently produced a defective and dangerous product and seek millions to repay families for the death of spouses, physically painful recoveries, lost wages and mental and emotional suffering.

Ohio illnesses in meningitis outbreak rise to 19 Ohio illnesses in meningitis outbreak rise to 19

Health officials say a 58-year-old Morrow County woman's fungal meningitis is the 19th case in Ohio linked to a larger outbreak and recalled steroid injections for back pain.

Ohio illnesses in meningitis outbreak rise to 18; latest case reported in Clermont County Ohio illnesses in meningitis outbreak rise to 18; latest case reported in Clermont County

Health officials say an 85-year-old Clermont County woman's fungal meningitis case marks Ohio's 18th illness linked to a larger outbreak and recalled steroid injections for back pain.